R&D update: Sun upbeat on gabapentin pro-drug and extended-release baclofen
This article was originally published in Scrip
Executive Summary
Sun Pharma Advanced Research Company (SPARC) is optimistic about the prospects for its pro-drug of gabapentin, SUN-44, and has filed a patent for the composition of matter of the compound internationally. SPARC is the demerged research arm of Sun Pharma of India.